Abintus Bio

Abintus Bio is a preclinical-stage gene therapy company specializing in the field of in vivo immune cell reprogramming. It is pioneering potentially curative, off-the-shelf gene medicines that directly engineer cells within patients, also known as in vivo. These therapies are based on Abintus' clinically validated Modular Delivery Platform (MDP).